CryoPort (CYRX)
(Delayed Data from NSDQ)
$8.28 USD
+0.49 (6.29%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $8.27 -0.01 (-0.12%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Brokerage Reports
CryoPort, Inc. [CYRX]
Reports for Purchase
Showing records 61 - 80 ( 197 total )
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Bioproduction: Tool Shares Weak but More Cell Therapy Catalysts
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
2022 Life Sciences & MedTech Investor Forum
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
2022 Life Sciences and MedTech Conference: Day 1 Takeaways
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Supply Chain Delays Drive Slight 4Q21 Miss, but Underlying Momentum Continuing
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
Fire and Manufacturing Site Shutdown Not Affecting Core CGT Business
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Returning to Buy Rating; Maintain $90.00 Price Target
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: CryoPort, Inc.
Industry: Transportation - Services
Get Bullish - 40% Sector Pullback Severely At Odds With Strong Growth Outlook
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
3Q21 Good Despite Supply Chain Headwinds; Moving to Neutral on Valuation
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Results Indicate Accelerating Cell & Gene Therapy Market
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
Annual ROTH Technology Conference (Virtual) - November 17-18
Provider: Roth Capital Partners, Inc.
Analyst: Research Department